home / stock / nonof / nonof news


NONOF News and Press, Novo-Nordisk A/S From 03/16/24

Stock Information

Company Name: Novo-Nordisk A/S
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com

Menu

NONOF NONOF Quote NONOF Short NONOF News NONOF Articles NONOF Message Board
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...

NONOF - NASH drug market expected to surpass $48B by 2035

2024-03-16 12:57:30 ET More on Madrigal Pharmaceuticals Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Ra...

NONOF - Eli Lilly Zepbound prescriptions exceed Novo's Wegovy for the first time in U.S.

2024-03-15 15:38:23 ET More on Eli Lilly Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Conference (Transcript) Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party UBS sees Lilly GLP-1/sl...

NONOF - Madrigal climbs amid hopes for new NASH drug; B. Riley upgrades

2024-03-15 08:19:55 ET More on Madrigal Pharmaceuticals Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's...

NONOF - Madrigal wins FDA approval for NASH therapy

2024-03-14 15:45:17 ET More on Madrigal Pharmaceuticals Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's...

NONOF - Biotech group backs anti-China bill; part ways with WuXi AppTec

2024-03-14 07:20:30 ET More on WuXi AppTec, WuXi AppTec, etc. Potential U.S. Targeting Casts Shadow Over WuXi AppTec Family WuXi Biologics: Recent Share Price Recovery Isn't Sustainable Historical earnings data for WuXi AppTec Dividend scorecard for WuXi AppT...

NONOF - Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified

2024-03-07 13:05:47 ET Summary Novo Nordisk had a strong performance in 2023, driven by a significant increase in obesity care sales and market leadership in the global diabetes market. The company plans to invest heavily in expanding its manufacturing base, with discussions of am...

NONOF - Labcorp introduces weight loss management portfolio

2024-03-07 09:33:18 ET More on Labcorp Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Call Transcript Laboratory Corporation of America Holdings 2023 Q4 - Results - Earnings Call Presentation Laboratory Corporation of America Q4 2023 Earnings Previe...

NONOF - Cigna in pact with Novo, Eli Lilly to widen obesity coverage

2024-03-07 06:43:36 ET More on Cigna Cigna: Trimming The Fat And Staying Focused Cigna: Big Buybacks And Total Return Potential The Cigna Group (CI) Q4 2023 Earnings Call Transcript Dividend Roundup: Southwest Airlines, Cigna, Deere, Gap, and more Pha...

NONOF - Eli Lilly said to have tapped National Resilience, BSP for Zepbound production

2024-03-05 13:02:26 ET More on Eli Lilly Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Eli Lilly price target upped at UBS on GLP...

NONOF - Prothena: Alzheimer's Data Update In 2024 Could Move The Needle

2024-02-23 12:31:39 ET Summary Prothena Corporation plc has an update coming on the phase 1 study using PRX012 for the treatment of patients with Alzheimer's Disease, expected in 2024. Company is already in the process of exploring the use of PRX012 for the treatment of patients w...

Previous 10 Next 10